Beressi N, Campos J M, Beressi J P, Franc B, Niccoli-Sire P, Conte-Devolx B, Murat A, Caron P, Baldet L, Kraimps J L, Cohen R, Bigorgne J C, Chabre O, Lecomte P, Modigliani E
Department of Endocrinology, University Paris XIII, Hopital Avicenne, Bobigny, France.
Thyroid. 1998 Nov;8(11):1039-44. doi: 10.1089/thy.1998.8.1039.
Clinical characteristics and prognosis of 80 patients (53 women and 27 men) with sporadic medullary thyroid carcinomas (MTC), less than 1 cm in size (micro-MTC), operated on between 1971 and 1996 are reported (73 total and 7 partial thyroidectomies). These patients, obtained from a national database of 899 patients with MTC, were compared with 357 cases of sporadic MTC greater than 1 cm and 149 subjects with familial MTC less than 1 cm (familial micro-MTC). Median age at surgery was 52.5 years, a distribution similar to larger sporadic MTC. Micro-MTC was identified due to elevated calcitonin (47.5%), clinically identified lymph node (10.0%), distant metastases (6.3%) or pathologic finding at surgery (36.2%). Diarrhea and/or flushing were observed in 6 patients including 4 with clinically identified lymph node. Among patients who had lymph node dissection at surgery (68.8%), lymph node involvement with tumor was observed in 30.9%, and was significantly more frequent in multifocal (7/11) than in unifocal micro-MTC (p < 0.03). All sporadic micro-MTC were unilateral. Survival rate was 93.9% +/- 4.4% (SE) at 10 years, greater than that observed in sporadic macro-MTC (p = 0.04). Normal postoperative basal calcitonin (CT) was obtained in 71.1% of micro-MTC patients versus 33.6% in sporadic macro-MTC (p < 0.01). Sporadic micro-MTC is much more frequent than expected, 15% of MTC in our series. Although specific survival rate and percentage of biological cure in micro-MTC are significantly better than for larger tumors, the frequency of lymph node involvement, however, justifies an aggressive surgical approach including total thyroidectomy and bilateral central lymph node dissection.
报告了1971年至1996年间接受手术治疗的80例(53例女性和27例男性)散发性甲状腺髓样癌(MTC)患者的临床特征和预后,肿瘤大小小于1 cm(微小MTC)(73例全甲状腺切除术和7例部分甲状腺切除术)。这些患者来自一个包含899例MTC患者的国家数据库,与357例肿瘤大于1 cm的散发性MTC患者以及149例肿瘤小于1 cm的家族性MTC患者(家族性微小MTC)进行了比较。手术时的中位年龄为52.5岁,这一分布与较大的散发性MTC相似。微小MTC的发现是由于降钙素升高(47.5%)、临床发现淋巴结(10.0%)、远处转移(6.3%)或手术中的病理发现(36.2%)。6例患者出现腹泻和/或潮红,其中4例有临床发现的淋巴结。在手术时进行了淋巴结清扫的患者中(68.8%),30.9%观察到肿瘤累及淋巴结,多灶性微小MTC(7/11)中这一情况比单灶性微小MTC更常见(p<0.03)。所有散发性微小MTC均为单侧。10年生存率为93.9%±4.4%(SE),高于散发性大MTC(p = 0.04)。微小MTC患者术后基础降钙素(CT)正常的比例为71.1%,而散发性大MTC患者为33.6%(p<0.01)。散发性微小MTC比预期更常见,在我们的系列中占MTC的15%。尽管微小MTC的特定生存率和生物学治愈百分比明显优于较大肿瘤,但淋巴结受累的频率表明应采取积极的手术方法,包括全甲状腺切除术和双侧中央淋巴结清扫。